Nuwellis (NUWE) Short-term Investments (2021 - 2023)

Nuwellis' (NUWE) quarterly Short-term Investments came in at $575000.0 in Q1 2023, up 1.05% on a QoQ basis from $569000.0 in Q4 2022.

Nuwellis (NUWE) Short-term Investments (2021 - 2023) Analysis & Trends

Nuwellis (NUWE) has 3 years of Short-term Investments data on file, last reported at $575000.0 in Q1 2023.

Quarterly Short-term Investments changed N/A year-over-year to $575000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $575000.0 (changed N/A YoY) and the FY2022 annual result came in at $569000.0, down 96.32% from the prior year.
Short-term Investments rose to $575000.0 in Q1 2023, from $569000.0 in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $15.5 million in Q4 2021 to a low of $569000.0 in Q4 2022.
A 3-year average of $5.5 million and a median of $575000.0 in 2023 frame the typical range for Short-term Investments.
The widest YoY moves for Short-term Investments: up 96.32% in 2022, down 96.32% in 2022.
Tracing NUWE's Short-term Investments over 3 years: stood at $15.5 million in 2021, then tumbled by 96.32% to $569000.0 in 2022, then increased by 1.05% to $575000.0 in 2023.
The last three Short-term Investments figures came in at $575000.0 (Q1 2023), $569000.0 (Q4 2022), and $15.5 million (Q4 2021), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Nuwellis	203,898.38	-3.72 Mn	1.50 Mn

Download Data